You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


AstraZeneca and Novavax say their vaccines are effective against Omicron

WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.